Literature DB >> 11705003

Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.

M D Ringel1.   

Abstract

The application of molecular analysis of gene expression to clinical tissue samples represents one of the most exciting new areas in "translational" thyroid cancer research. Current data suggest that molecular diagnostic assays may improve the sensitivity and accuracy of fine needle aspiration of thyroid nodules, fine needle aspiration of metastases, and detection of recurrent disease in peripheral blood samples. It is likely that at least some of these tests will become useful adjuncts in the diagnostic armamentarium of clinical endocrinologists in the future.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11705003     DOI： 10.1023/a:1010027014324

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


  62 in total

1.  Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.

Authors:  K Ohyashiki; J H Ohyashiki; J Nishimaki; K Toyama; Y Ebihara; H Kato; W E Wright; J W Shay
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

2.  TSH beta subunit gene expression in human lymphocytes.

Authors:  M E Peele; F E Carr; J R Baker; L Wartofsky; K D Burman
Journal:  Am J Med Sci       Date:  1993-01       Impact factor: 2.378

3.  Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow.

Authors:  E Corey; E W Arfman; A Y Liu; R L Vessella
Journal:  Clin Chem       Date:  1997-03       Impact factor: 8.327

4.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

5.  Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.

Authors:  M Miettinen; P Kärkkäinen
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

6.  Telomerase activity in human thyroid carcinomas originating from the follicular cells.

Authors:  P Brousset; N Chaouche; F Leprat; F Branet-Brousset; H Trouette; R C Zenou; J P Merlio; G Delsol
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Detection and characterization of carcinoma cells in the blood.

Authors:  E Racila; D Euhus; A J Weiss; C Rao; J McConnell; L W Terstappen; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies.

Authors:  T Takano; A Miyauchi; T Yokozawa; F Matsuzuka; G Liu; T Higashiyama; S Morita; K Kuma; N Amino
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

9.  Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.

Authors:  M D Ringel; P W Ladenson; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

10.  Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.

Authors:  X C Xu; A K el-Naggar; R Lotan
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307
View more
  2 in total

1.  Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.

Authors:  Lewis M Brown; Steve M Helmke; Stephen W Hunsucker; Romana T Netea-Maier; Simon A Chiang; David E Heinz; Kenneth R Shroyer; Mark W Duncan; Bryan R Haugen
Journal:  Mol Carcinog       Date:  2006-08       Impact factor: 4.784

2.  Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach.

Authors:  Reyhaneh Farrokhi Yekta; Mostafa Rezaei Tavirani; Afsaneh Arefi Oskouie; Mohammad Reza Mohajeri-Tehrani; Ahmad Reza Soroush; Alireza Akbarzadeh Baghban
Journal:  Iran J Basic Med Sci       Date:  2018-11       Impact factor: 2.699
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.